Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

daclatasvir

daclatasvir
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Daklinza TABLET, ORAL 30 mg, 60 mg      
Comments:

Daklinza -- Non-formulary, not stocked.  Cost is about $750/dose.  Defer initiation to after discharge (for chronic hepatitis C).  Patient should use home drug supply for in hospital use.

Reviewed: 17 Nov 2015 (Daklinza)

Drug removed from US Market 4/30/2019

Last updated: Mar. 12, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved